AST (Aspartate Aminotransferase): What the AST-to-ALT Ratio Reveals

What AST actually is and where it leaks from

AST is an enzyme found in liver cells, skeletal muscle, heart, and red blood cells. It plays a role in amino acid and energy metabolism, converting aspartate and alpha-ketoglutarate into oxaloacetate and glutamate. When those cells are stressed or injured, AST leaks into the bloodstream — rising levels signal cell membrane leakiness, while falling levels suggest injury is calming down. A high result can reflect liver strain, muscle damage, or even a difficult blood draw; the work is figuring out which.

The liver and muscle biology behind AST

AST sits in two compartments inside cells: the cytosol and the mitochondria. Mild, short-lived stress tends to release cytosolic AST; deeper, more intense injury can spill mitochondrial AST. That distinction is one reason patterns and persistence matter more than any single number.

AST does not measure liver function — it does not reflect synthetic capacity or detoxification. It measures cell membrane leakiness. When AST is higher than ALT, clinicians consider alcohol-related injury, advanced fibrosis, or muscle sources. When ALT is higher, they lean toward liver-first processes such as viral hepatitis or fatty liver inflammation. AST requires vitamin B6 as a cofactor, which means B6 deficiency can suppress the assay result and cause both AST and ALT to read falsely low.

Persistently elevated AST tied to liver disease predicts higher risk of cirrhosis and its complications over time. In older adults, the AST-to-ALT ratio often rises as ALT declines with age, and higher ratios have been linked to increased all-cause mortality, likely reflecting broader changes in body composition and frailty.

Low, normal, and high AST explained

Reference intervals are statistical ranges built from a population, not "healthy or sick" labels. Different labs use different methods and reference groups, so a result that looks borderline in one lab may appear normal in another. An isolated AST value is a conversation starter, not a conclusion; trends over time alongside related markers tell the fuller story.

Normal

A typical reference range is roughly 10–40 U/L, though exact cutoffs vary by laboratory and assay method. Men tend to run slightly higher than women due to greater muscle mass. Pregnancy may lower values modestly. Because population-derived ranges include people with subclinical liver or metabolic disease, a result within range does not automatically mean optimal — lower and stable generally aligns with less ongoing liver or muscle injury.

Low

Low AST can mean low cellular injury, which is generally favorable. However, extremely low numbers are not a trophy. Vitamin B6 deficiency — common in older adults or people with limited diets — can suppress the AST assay and cause falsely low readings. Low muscle mass and certain assay methods can also shift results downward. Importantly, the American Association for the Study of Liver Diseases notes that aminotransferases can be normal in people with nonalcoholic fatty liver disease, so a low or normal result does not rule out ongoing liver pathology.

High

An elevated AST generally falls into one of three broad categories: liver stress, muscle stress, or sample issues. On the liver side, common contributors include alcohol exposure, metabolic fatty liver, viral hepatitis, certain medications, and toxin exposure such as acetaminophen overdose. On the muscle side, strenuous exercise, contact sports, and conditions like rhabdomyolysis are typical causes. Hemolysis during a difficult blood draw can also raise AST because red blood cells carry the enzyme.

Patterns help narrow the differential. If ALT rises alongside AST and GGT is also elevated, a liver origin becomes more likely. If creatine kinase (CK) is high with AST, muscle is the primary suspect. If bilirubin or alkaline phosphatase rise, biliary involvement may be present. If platelets drift low alongside elevated AST, fibrosis risk enters the picture through scores such as APRI or FIB-4.

The AST-to-ALT ratio adds further context: a ratio above 2 can point toward alcohol-related injury or advanced scarring, while a ratio below 1 is more common in fatty liver without significant fibrosis. Strenuous exercise can distort this ratio because muscle releases more AST than ALT. Persistent elevation, alignment with symptoms, and concordance with other labs are the key questions that determine whether further evaluation is warranted.

Factors that shift your AST result

Several biological, behavioral, and technical factors can move AST independent of underlying liver disease.

• Alcohol — the single biggest driver of alcohol-related AST elevation. Cessation typically produces a measurable response within 2–8 weeks.
• Intense or unaccustomed exercise — a transient spike from muscle micro-tears is expected; levels generally normalize within 48–72 hours. Avoiding strenuous exercise in the 48 hours before a draw reduces this confounding effect.
• Liver fat and insulin resistance (MASLD) — metabolic dysfunction primes hepatocytes to leak enzymes; improving insulin sensitivity and reducing liver fat tends to lower transaminases over months.
• Sleep debt and obstructive sleep apnea (OSA) — disrupted circadian rhythms shift liver metabolism, raise cortisol, and promote hepatic fat accumulation, all of which can elevate AST over time.
• Medications and supplements — statins can cause mild, usually transient elevations; acetaminophen, isoniazid, certain antibiotics, and some bodybuilding supplements can raise enzymes more substantially; GLP-1–based therapies tend to lower transaminases as liver fat falls with weight loss.
• Vitamin B6 deficiency — because B6 is a required cofactor for the AST reaction, deficiency suppresses the assay and can cause falsely low results, particularly in older adults or those with limited dietary variety.
• Macro-AST artifact — a benign enzyme-immunoglobulin complex can falsely elevate AST on standard assays without any underlying tissue injury; simple laboratory techniques can identify it.

Markers that read AST in context

AST is most informative when interpreted alongside a small set of related markers.

• Alanine aminotransferase (ALT) — ALT is more liver-specific than AST; when ALT is higher than AST, the elevation is more likely a primary hepatocellular process. When AST dominates with a ratio above 2, alcohol-related injury or a muscle contribution is suggested.
• Gamma-glutamyl transferase (GGT) — GGT rises with biliary stress and alcohol exposure; when GGT and AST are both elevated, alcohol-related or cholestatic liver injury moves up the differential.
• Alkaline phosphatase (ALP) — the combination of ALP with AST and ALT helps distinguish cholestatic from hepatocellular injury patterns; an ALP-dominant rise with only modest transaminase elevation points toward bile duct obstruction.
• Ferritin — ferritin is a sensitive marker of metabolic liver inflammation and iron overload (including hemochromatosis), both common causes of elevated AST; pairing the two clarifies whether an elevation reflects an acute-phase response or a chronic storage problem.
• Platelet count — combined with AST and ALT, platelet count unlocks the APRI and FIB-4 fibrosis scores, which estimate cirrhosis risk without imaging; low platelets alongside elevated AST is a clinically significant pattern.

A realistic retest window for AST

AST has a half-life of approximately 17 hours, meaning levels can begin to fall within days of removing the trigger. When monitoring a lifestyle intervention — such as alcohol cessation, weight loss, or statin discontinuation — a retest at 8–12 weeks is a reasonable window to detect a meaningful response.

Because a single elevated result can reflect a transient cause (a hard workout, a viral illness, a difficult blood draw), a meaningfully elevated AST warrants confirmation on a second draw before pursuing further workup. This separates transient from persistent elevation and avoids unnecessary investigation.

For consistent results, use the same laboratory, draw at the same time of day, and avoid strenuous exercise in the 48 hours before the draw to prevent muscle-derived confounding.

When AST results warrant a provider conversation

A single mildly elevated AST — particularly after intense exercise, a viral illness, or a difficult draw — often resolves on its own and can be confirmed with a repeat test before any workup begins. The situations that warrant a prompt conversation with a clinician include:

• AST that remains elevated on a second draw 8–12 weeks later without a clear transient explanation
• AST more than three times the upper limit of normal
• Elevation accompanied by symptoms such as fatigue, jaundice, right upper quadrant discomfort, or unexplained weight change
• A rising AST-to-ALT ratio, particularly above 2, without a known muscle cause
• Low platelets alongside elevated AST, which raises the possibility of fibrosis
• Elevation during pregnancy, which should prompt prompt review
• Persistent elevation without an identifiable cause, where macro-AST artifact should be considered

Trending AST alongside its companion markers — ALT, GGT, ALP, ferritin, and platelet count — turns a single enzyme into a readable map of liver and muscle health. Small, consistent changes in behavior show up in the numbers over weeks and months, making AST a practical feedback tool for anyone paying attention to long-term resilience.

Superpower's approach to biomarker testing is built on this kind of longitudinal, contextual reading — pairing AST with the full panel it needs to be meaningful, and connecting results to clinicians who can act on them. Learn more at superpower.com or read about the approach.